BMI1 and osteosarcoma: Indeed, BMI1 expression was found to be upregulated in both human and canine osteosarcoma cell lines, and its inhibition in vitro significantly reduced cell proliferation and increased sensitivity to carboplatin and doxorubicin in different canine lines.